Clinical Trials at Atrium Health Wake Forest Baptist
As of September 2026, 35 paid clinical trials are recruiting at Atrium Health Wake Forest Baptist, located at Atrium Health Wake Forest Baptist Ward A. Riley Ultrasound Center, 2000 W 1st St Ste 504, Winston-Salem, NC 27104, phone (336) 716-0644 in Winston-Salem, North Carolina. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Multiple Myeloma and Malignant Solid Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Winston-Salem
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Pelashield vs Xeroform
Placental Cells for Diabetic Foot Ulcers
38 clinical trials at Atrium Health Wake Forest Baptist
·Clear filters·Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Tracking Results of Ablations to Combat AF Registry Generation 2
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation™ (MTR®) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients
Incremental Hemodialysis: The TwoPlus Trial
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Primary Subtalar Arthrodesis for Calcaneal Fractures
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
The Myelin Disorders Biorepository Project
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Total Intravenous Anesthesia (TIVA)/Sevoflurane Initiated Intravenous Anesthesia (SIIVA) in Pediatric Patients
Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems
Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Common conditions studied in Winston-Salem
- Acute Myeloid Leukemia (11 active studies)
- Multiple Myeloma (10 active studies)
- Cancer (9 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Breast Cancer (5 active studies)
- Chronic Pain (5 active studies)
Leading research sponsors in Winston-Salem
- Wake Forest University Health Sciences
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Winston-Salem?
There are approximately 527 recruiting clinical trials in Winston-Salem, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Winston-Salem pay participants?
Most recruiting trials in Winston-Salem compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Winston-Salem?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Winston-Salem?
The most common conditions under active study in Winston-Salem include Acute Myeloid Leukemia (11), Multiple Myeloma (10), Cancer (9), Malignant Solid Neoplasm (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Winston-Salem?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Winston-Salem on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Winston-Salem?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Winston-Salem?
Recruiting research sites in Winston-Salem include Wake Forest University Health Sciences, Atrium Health Wake Forest Baptist, Wake Forest University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Winston-Salem right now?
The largest active categories in Winston-Salem are Cancer & tumors (155), Neurology & pain (34), Cardiovascular (30). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Atrium Health Wake Forest Baptist?
Atrium Health Wake Forest Baptist is located at Atrium Health Wake Forest Baptist Ward A. Riley Ultrasound Center, 2000 W 1st St Ste 504, Winston-Salem, NC 27104. Use the Google Maps link in the intro above to get directions.
How do I contact Atrium Health Wake Forest Baptist?
You can reach Atrium Health Wake Forest Baptist by phone at (336) 716-0644. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.